Percutaneous Vertebroplasty: Prophylactic Treatment of Adjacent Vertebra
NCT ID: NCT00635297
Last Updated: 2010-03-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
100 participants
INTERVENTIONAL
2008-04-30
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of the study is to determine if prophylactic vertebroplasty of unfractured vertebrae adjacent to the treated fractured vertebrae can reduce the rates of refracture in adjacent vertebrae.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study About the Effect of Preventive Adjacent Level Cement Augmentation After Osteoporotic Vertebral Compression Fractures
NCT02489825
VertebrOpLasty Versus Conservative Treatment in Acute Non Osteoporotic Vertebral Fractures
NCT01643395
Postrual Reduction With Pillow in Osteoporotic Vertebral Fracture
NCT03451305
Early Percutaneous Vertebroplasty Versus Standard Conservative Treatment in Thoracolumbar Vertebral Fractures
NCT03617094
CT Guided Percutaneous Vertebroplasty for Vertebral Non-union Following Posterior Fixation
NCT05071625
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
50 osteoporotic patients with a vertebral insufficiency fracture will receive treatment of the vertebrae with standard vertebroplasty
Percutaneous vertebroplasty
PMMA injection 3-10 milliliter in each treated vertebrae
2
50 osteoporotic patients with a vertebral insufficiency fracture will receive treatment of the vertebrae with standard vertebroplasty. The adjacent vertebrae will be treated with 3-5 ml of PMMA
Percutaneous vertebroplasty
PMMA injection 3-10 milliliter in each treated vertebrae
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Percutaneous vertebroplasty
PMMA injection 3-10 milliliter in each treated vertebrae
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* High grade spinal stenosis
* Contraindications to MRI
* Dementia
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ullevaal University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ullevål universitetssykehus HF
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Per Hj Nakstad, Phd
Role: STUDY_DIRECTOR
Nevroradiologisk avdeling Ullevål Universitetssykehus HF
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nevroradiologisk avdeling Ullevål universitetssykehus HF
Oslo, Oslo County, Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
889 VP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.